NCT04521192View on ClinicalTrials.gov

Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 6, 2019

Primary Completion Date

July 26, 2019

Study Completion Date

September 5, 2019

Conditions
Healthy Adult Subjects
Interventions
DRUG

Fluzoparib

the first period: test preparation; the second period: reference preparation

DRUG

Fluzoparib

the first period: reference preparation the second period: test preparation

Trial Locations (1)

Unknown

The affiliated hospital of QingDao university, Qingdao

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04521192 - Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects | Biotech Hunter | Biotech Hunter